HOME >> BIOLOGY >> NEWS
Manchester to spearhead 8.3 million particle physics project

The University of Manchester is leading an 8.3 million drive to develop a new type of particle accelerator, which could lead to more effective cancer treatment, greener electricity and less nuclear waste.

Particle accelerators are used to produce beams of charged particles such as protons or electrons, which are then used for a wide variety of applications in medicine and industry and for pure scientific research.

Researchers say there is a compelling need for new types of accelerator that are easier to operate and maintain, are more reliable and compact, yet are more flexible and efficient.

One such accelerator is the 'non-scaling fixed field alternating gradient' (NS-FFAG) accelerator.

It is considered a very promising candidate, but no-one has yet built such a machine, and there are many technical challenges to be overcome before such a machine could be used commercially.

The new CONFORM* project has received 7.5 million funding from the Engineering and Physical Sciences Research Council (EPSRC).

The research is being led Professor Roger Barlow from The School of Physics and Astronomy at The University of Manchester, in collaboration with Science and Technology Facilities Council (formerly the CCLRC) at the Daresbury Laboratory, The Cockroft Institute (also based at The Daresbury Laboratory), The University of Oxford, Imperial College London, The University of Birmingham, The University of Surrey, The University of Leeds, The University of Glasgow and The Gray Cancer Institute.

Professor Barlow said: "An opportunity is arising which could allow the NS-FFAG to be used as a new type of charged particle therapy machine for treating cancer. The reduced size, increased reliability and flexibility of such machines should all lead to lower costs of ownership while delivering more effective therapies."

Professor Barlow adds that beams of protons or heavier particles such as carbon ions can
'"/>

Contact: Alex Waddington
alex.waddington@manchester.ac.uk
01-613-063-983
University of Manchester
2-May-2007


Page: 1 2

Related biology news :

1. Manchester University helps with pharaoh DNA analysis
2. University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis
3. Manchester researcher wins Libyan award
4. 3M Manchester research center to develop vital new science
5. Study suggests morning pollution pall for Manchester commuters
6. Manchester plays host to international genetics network
7. Manchester scientists create new bio-gel for 3D cell culture
8. University of Manchester pioneers study to support teenage mums bone health
9. 2 MSU professors spearhead international water project
10. US Department of Defense awards $1.6 million for implantable biochip research
11. Nottingham biosciences million pound injection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:6/28/2020)... ... , ... In an upcoming episode scheduled for the fall of 2020, Advancements ... (POCT). Check local listings for more info. , Today, the majority of testing is ... labs throughout the country. Results are then available several days later. Now, in an ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... is pleased to announce the next event in a series of TOPIQ webinars, ... The TOPIQ series of webinars was developed in response to social distancing measures ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... LEXINGTON, Mass. (PRWEB) , ... August 11, 2020 ... ... awarded $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial ... year in 2021 and 2022. The network is a consortium of academic research ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter ... of a successful study, while protecting and accessing the catheter or device post-surgery is ... from Envigo in a live webinar on Wednesday, August 5, ...
Breaking Biology Technology:
Cached News: